1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Round Cell Liposarcoma Global Clinical Trials Review, H1, 2015

Round Cell Liposarcoma Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Round Cell Liposarcoma Global Clinical Trials Review, H1, 2015" provides data on the Round Cell Liposarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Round Cell Liposarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Round Cell Liposarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Round Cell Liposarcoma Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Round Cell Liposarcoma 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Round Cell Liposarcoma to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Round Cell Liposarcoma to Oncology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Round Cell Liposarcoma Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Johnson and Johnson 28
Clinical Trial Overview of Johnson and Johnson 28
F. Hoffmann-La Roche Ltd. 29
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 29
Eisai Co., Ltd. 30
Clinical Trial Overview of Eisai Co., Ltd. 30
Clinical Trial Overview of Top Institutes / Government 31
Fred Hutchinson Cancer Research Center 31
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 31
European Organization for Research and Treatment of Cancer 32
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 32
Vector Oncology 33
Clinical Trial Overview of Vector Oncology 33
St. Jude Children's Research Hospital 34
Clinical Trial Overview of St. Jude Children's Research Hospital 34
Fondazione IRCCS - Istituto Nazionale dei Tumori 35
Clinical Trial Overview of Fondazione IRCCS - Istituto Nazionale dei Tumori 35
Istituto Nazionale per lo Studio e la Cura dei Tumori 36
Clinical Trial Overview of Istituto Nazionale per lo Studio e la Cura dei Tumori 36
Five Key Clinical Profiles 37
Appendix 71
Abbreviations 71
Definitions 71
Research Methodology 72
Secondary Research 72
About GlobalData 73
Contact Us 73
Disclaimer 73
Source 73

List of Tables
Round Cell Liposarcoma Therapeutics, Global, Clinical Trials by Region, 2015* 6
Round Cell Liposarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Round Cell Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Round Cell Liposarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 9
Round Cell Liposarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 10
Round Cell Liposarcoma Therapeutics Clinical Trials, North America, Top Countries, 2015* 11
Round Cell Liposarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 12
Round Cell Liposarcoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 13
Proportion of Round Cell Liposarcoma to Oncology Clinical Trials, G7 Countries (%), 2015* 14
Round Cell Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Round Cell Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Round Cell Liposarcoma to Oncology Clinical Trials, E7 Countries (%), 2015* 17
Round Cell Liposarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Round Cell Liposarcoma Therapeutics, Global, Clinical Trials by Phase, 2015* 19
Round Cell Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 20
Round Cell Liposarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21
Round Cell Liposarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22
Round Cell Liposarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23
Round Cell Liposarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 24
Round Cell Liposarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25
Round Cell Liposarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26
Round Cell Liposarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27
Round Cell Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2015* 28
Round Cell Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 29
Round Cell Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 30
Round Cell Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2015* 31
Round Cell Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015* 32
Round Cell Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Vector Oncology, 2015* 33
Round Cell Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children's Research Hospital, 2015* 34
Round Cell Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fondazione IRCCS - Istituto Nazionale dei Tumori, 2015* 35
Round Cell Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Istituto Nazionale per lo Studio e la Cura dei Tumori, 2015* 36

List of Figures
Round Cell Liposarcoma Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Round Cell Liposarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Round Cell Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Round Cell Liposarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 9
Round Cell Liposarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 10
Round Cell Liposarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 11
Round Cell Liposarcoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 13
Proportion of Round Cell Liposarcoma to Oncology Clinical Trials, G7 Countries (%), 2015* 14
Round Cell Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Round Cell Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Round Cell Liposarcoma to Oncology Clinical Trials, E7 Countries (%), 2015* 17
Round Cell Liposarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Round Cell Liposarcoma Therapeutics, Global, Clinical Trials by Phase (%), 2015* 19
Round Cell Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 20
Round Cell Liposarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21
Round Cell Liposarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22
Round Cell Liposarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23
Round Cell Liposarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 24
Round Cell Liposarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25
Round Cell Liposarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26
Round Cell Liposarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27
GlobalData Methodology 72

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies

Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies

  • $ 4995
  • Industry report
  • September 2016
  • by GBI Research

Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies Summary Gastric cancer is characterized by the formation of malignant ...

Human Papillomavirus Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Human Papillomavirus Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • October 2016
  • by Global Data

Human Papillomavirus Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Human Papillomavirus Diagnostic Tests - Medical Devices Pipeline ...

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • September 2016
  • by Global Data

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" ...


Download Unlimited Documents from Trusted Public Sources

Pathology Statistics in the US and the UK

  • December 2016
    12 pages
  • Pathology  

    Digestive Syste...  

    Cancer  

  • United States  

    United Kingdom  

View report >

Pathology Statistics in the US and the UK

  • December 2016
    13 pages
  • Pathology  

    Digestive Syste...  

  • United States  

    United Kingdom  

View report >

Biological Therapy Industry - Forecast

  • December 2016
    13 pages
  • Cancer  

    Lymphoma  

View report >

Related Market Segments :

Clinical Trial
Therapy

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.